Stanley Plotkin, MD

Consultant and Emeritus Professor, University of Pennsylvania, Vaxconsult, LLP

Paul Offit, MD

Director, Vaccine Education Center, Division of Infectious Diseases, Children's Hospital of Philadelphia.

William C. Gruber, MD

SVP Vaccine Clinical Research and Development, Pfizer Inc

Karin Bok, MS, PhD

Director of Pandemic Preparedness and Emergency Response, Vaccine Research Center, NIAID, NIH

John Howard, MS, MBA

President and Founder, Applied Biotechnology Institute, Inc (ABI)

Drew Weissman, MD, PhD

Professor, Department of Medicine, Director of Vaccine Research, Infectious Diseases Division, Perelman School of Medicine, University of Pennsylvania

Kizzmekia S. Corbett, Ph.D

Assistant Professor of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health

Kayvon Modjarrad, M.D., Ph.D

Director, Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research

Olivera (Olja) J. Finn, M.D.

Distinguished Professor, Department of Immunology, University of Pittsburgh School of Medicine

Ruxandra Draghia-Akli, MD, Ph.D

Global Head, Global Public Health R&D, Johnson & Johnson

Jay A. Berzofsky, M.D., Ph.D.

Chief, Vaccine Branch,
Center for Cancer Research,
National Cancer Institute

Alessandro Sette Dr Biol Sci

Professor and Member, Infectious Disease and Vaccine Center, La Jolla Institute for Immunology

Adrian V.S. Hill MD, Ph.D.

Director, The Jenner Institute, Nuffield Department of Medicine, University of Oxford

Raches Ella, MBBS, MS

Head - Business Development & Advocacy, Bharat Biotech

Nikolai Petrovsky, MBBS, Ph.D

Flinders University, Australia, Research Director, Vaxine Pty Ltd

Nathalie Garcon, Ph.D.

CEO, CSO, BIOASTER

Karen A. Norris, Ph.D.

Professor, Georgia Research Alliance Eminent Scholar, Charles H. Wheatley Chair in Immunology and Translational Biomedical Research, Center for Vaccines and Immunology, Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia

Ralph S. Baric, Ph.D.

University of North Carolina Kenan Distinguished Professor, Epidemiology, Gillings School of Global Public Health and Microbiology and Immunology, School of Medicine.

Alexander Bukreyev, Ph.D.

Professor, Co-Principal Investigator Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus, Departments of Pathology and Microbiology & Immunology, University of Texas Medical Branch

Kenneth D. Stuart, Ph.D.

Professor, University of Washington School of Medicine, Department of Pediatrics and Seattle Children’s Research Institute, Center for Global Infectious Disease Research (CGIDR)

James E. Crowe, Jr., M.D.

Director, Vanderbilt Vaccine Center

Michael Schotsaert, Ph.D

Assistant Professor, Microbiology, Icahn School of Medicine at Mount Sinai

Joseph A. Vetro, Ph.D.

Associate Professor, Department of Pharmaceutical Sciences, University of Nebraska Medical Center

Leonidas Stamatatos, Ph.D.

Professor, Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division

Stephen Albert Johnston, Ph.D

Co-Founder, Calviri, Inc

Barbara A. Jones, Ph.D

IBM Research Almaden

Denise L Faustman, M.D., Ph.D.

Director of Immunobiology, Massachusetts General Hospital, Associate Professor of Medicine, Harvard Medical School

Peter Palese, PhD

Horace W. Goldsmith Professor and Chair, Department of Microbiology, Professor, Department of Medicine, Icahn School of Medicine at Mount Sinai

Seshadri S. Vasan, DPhil(Oxon)

Honorary Professor of Health Sciences, University of York, UK

Thomas Tillett, PhD

CEO, MBF Therapeutics

Li Shi, PhD

Yidao Biotechnology CO., Ltd

Tomas Hanke, PhD

The Jenner Institute, Nuffield Department of Medicine, University of Oxford

M. Javad Aman, PhD

President and CSO, Integrated Biotherapeutics Inc.,

Paul LaBarre, MS, MBA

Vice President of Global Business Development, PharmaJet

Stéphane Pillet, PhD

Clinical Immunology Manager, Scientific and Medical Affairs, Medicago

Raiees Andrabi, PhD

Institute Investigator, Department of Immunology and Microbiology, The Scripps Research Institute

Philip R Krause

Former FDA Deputy Director, Office of Vaccines Research and Review, Consultant, World Health Organization

Andrew M. Lewis JR., MD

Office of Vaccines Research and Review, Division of Viral Products, Laboratory of DNA Viruses

Pravin T.P. Kaumaya, PhD

Professor Ob/Gyn, Molecular and Cellular Biochemistry, Director Div. of VACCINE DEVELOPMENT/ Peptide & Protein Engineering Laboratory

Steve Steinhubl, MD

Chief Medical Officer, physIQ

Yang Xu, PhD

Director and full professor, Shanghai University of Medicine and Health Sciences

Shelly J. Krebs, PhD

Chief, B cell Biology I HJF, In support of the US Military HIV Research Program (MHRP), and the Emerging Infectious Disease Branch (EIDB), Walter Reed Army Institute of Research (WRAIR)

Theodore (Ted) Schenkelberg, MBA, MPH

Senior Vice President and Chief Strategy Officer, Human Vaccines Project

Jonathan Lovell, PhD

Associate Professor of Biomedical Engineering, University at Buffalo

Marco Pravetoni, PhD

Professor of Psychiatry and Behavioral Sciences, University of Washington School of Medicine; Director, Center for Medication Development for Substance Use Disorders and Overdose

Catarina Hioe, PhD

Professor, Medicine, Infectious Diseases, Icahn School of Medicine at Mount Sinai